Related Experiment Videos
Th2-type cytokines modulate IL-6 release by human bronchial epithelial cells
1Department of Immunology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. striz@mbox.cesnet.cz
Immunology Letters
|November 24, 1999
Summary
Interleukin-4 (IL-4) and Interleukin-13 (IL-13) modulate interleukin-6 (IL-6) release from human bronchial epithelial cells (HBECs). These Th2 cytokines inhibit TNF-alpha-induced IL-6 release and augment IFN-gamma-induced IL-6 release, impacting allergic responses.
Area of Science:
- Immunology
- Respiratory Medicine
- Cell Biology
Background:
- The cytokine Interleukin-6 (IL-6) is produced by human bronchial epithelial cells (HBECs) and influences IgE synthesis.
- Allergic reactions in asthma involve increased IL-4 and Th2 immune responses.
- Understanding cytokine regulation of IL-6 in HBECs is crucial for asthma research.
Purpose of the Study:
- To investigate whether IL-4, IL-10, and IL-13 regulate IL-6 release from HBECs.
- To determine the role of Th2 cytokines in modulating IL-6 production in the context of allergic airway inflammation.
Main Methods:
- Human bronchial epithelial cells (HBECs) were cultured and stimulated with various cytokines (IL-4, IL-10, IL-13, TNF-alpha, IFN-gamma).
- IL-6 levels in cell supernatants were quantified using sandwich ELISA.
- Statistical analysis was performed to assess significant changes in IL-6 release.
Main Results:
- HBECs spontaneously produced IL-6.
- IL-4 significantly increased IL-6 release, while IL-10 and IL-13 had minimal effects alone.
- IL-4 and IL-13 significantly inhibited TNF-alpha-induced IL-6 release but augmented IFN-gamma-induced IL-6 release.
Conclusions:
- Th2 cytokines IL-4 and IL-13 modulate IL-6 release from HBECs, affecting responses to other inflammatory signals.
- IL-10 did not significantly affect IL-6 release in this model.
- Modulation of IL-6 by Th2 cytokines may contribute to allergic reactions by influencing IL-4-mediated IgE production.